Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MRNA

Moderna Inc

Sep 13 • 03:15PM ET

67.49

Dollar change -2.19
Percentage change -3.14	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VOO VO QQQ VUG VOT SPY IVV XLV IBB

Scroll to Statements

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-15.38	Insider Own	10.86%	Shs Outstand	382.00M	Perf Week	-7.41%
Market Cap	25.94B	Forward P/E	-	EPS next Y	-8.01	Insider Trans	-1.41%	Shs Float	342.64M	Perf Month	-17.95%
Income	-5867.00M	PEG	-	EPS next Q	-1.85	Inst Own	67.95%	Short Float	7.48%	Perf Quarter	-53.53%
Sales	5.04B	P/S	5.15	EPS this Y	22.35%	Inst Trans	0.89%	Short Ratio	6.19	Perf Half Y	-34.77%
Book/sh	30.50	P/B	2.21	EPS next Y	16.37%	ROA	-31.24%	Short Interest	25.63M	Perf Year	-37.85%
Cash/sh	22.08	P/C	3.06	EPS next 5Y	-	ROE	-40.94%	52W Range	62.55 - 170.47	Perf YTD	-32.14%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-20.02%	ROI	-45.28%	52W High	-60.41%	Beta	1.69
Dividend TTM	-	Quick Ratio	3.92	Sales past 5Y	662.08%	Gross Margin	22.47%	52W Low	7.90%	ATR (14)	4.70
Dividend Ex-Date	-	Current Ratio	4.09	EPS Y/Y TTM	-601.75%	Oper. Margin	-92.09%	RSI (14)	28.05	Volatility	5.85% 4.48%
Employees	5600	Debt/Eq	0.11	Sales Y/Y TTM	-52.22%	Profit Margin	-116.36%	Recom	2.62	Target Price	102.47
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	8.04%	Payout	-	Rel Volume	2.71	Prev Close	69.68
Sales Surprise	87.68%	EPS Surprise	0.54%	Sales Q/Q	-29.94%	Earnings	Aug 01 BMO	Avg Volume	4.14M	Price	67.49
SMA20	-15.18%	SMA50	-30.30%	SMA200	-36.45%	Trades		Volume	9,984,262	Change	-3.14%

Date	Action	Analyst	Rating Change	Price Target Change
Today	Downgrade	Oppenheimer	Outperform → Perform
Today	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Today	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60
Aug-04-23	Downgrade	TD Cowen	Outperform → Market Perform	$145 → $125
Aug-03-23	Downgrade	Deutsche Bank	Buy → Hold	$125
Jul-24-23	Initiated	William Blair	Mkt Perform	$136.28
Jul-14-23	Initiated	HSBC Securities	Reduce	$97
Jun-26-23	Upgrade	UBS	Neutral → Buy	$221 → $191
Apr-26-23	Initiated	Guggenheim	Neutral
Mar-13-23	Upgrade	TD Cowen	Market Perform → Outperform	$150 → $180
Mar-02-23	Initiated	RBC Capital Mkts	Outperform	$200
Feb-24-23	Downgrade	SVB Securities	Market Perform → Underperform	$111 → $93

Show Previous Ratings

Today 02:18PM	Midday stock movers: Adobe, Boeing, Moderna (TheStreet)
12:54PM	Top Stock Movers Now: Uber, Adobe, Etsy, and More (Investopedia)
10:31AM	Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day (Investor's Business Daily)
09:59AM	Moderna stock slides on downgrades tied to profitability delay (Yahoo Finance Video)
09:33AM	Moderna, Halliburton downgraded: Wall Street's top analyst calls (The Fly)
09:09AM	Loading…
09:09AM	Moderna Stock Falls Again. How the Drug Maker Can Turn Things Around. (Barrons.com)
08:42AM	Analyst Report: Moderna, Inc. (Morningstar Research)
08:01AM	Is Moderna Stock A Sell After The Company Slashed Its Sales Guide, R&D Budget? (Investor's Business Daily)
07:30AM	A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now (Motley Fool)
06:12AM	ESMO: Modernas mRNA solid tumour vaccine shows early promise (Clinical Trials Arena)
05:45AM	Moderna shares slip premarket as analysts cut ratings amid guidance worries (Investing.com)
Sep-12-24 05:19PM	Modernas CEO Sees an Evolution of Strategy. The Stock Hits Lowest Level Since 2020. (Barrons.com) -12.36%
05:13PM	Moderna Stock Falls 12% After Vaccine Maker Cuts R&D Plans, Drugs Pipeline (The Wall Street Journal)
04:53PM	S&P 500 Gains and Losses Today: Moderna Stock Plunges as Firm Plans R&D Cuts (Investopedia)
04:06PM	Moderna Crashes After Slashing Its R&D Budget, Sales Guidance (Investor's Business Daily)
03:35PM	Loading…
03:35PM	3-Stock Lunch: Moderna, Delta Air Lines (CNBC TV)
03:10PM	Moderna Cost Cuts Fail to Restore Investor Trust (The Wall Street Journal)
03:10PM	Indexes Rally As Nasdaq, Nvidia Clear Important Levels; Cathie Wood Unloads AI Leader After 100% Gain (Live Coverage) (Investor's Business Daily)
02:55PM	Moderna stock plunges nearly 20% as company reports poor COVID-19 vaccine sales and cuts to research plans (FastCompany)
02:05PM	Midday stock movers: Kroger, Alaska Air, Moderna (TheStreet)
01:54PM	Indexes Rally As Nvidia Clears Important Level; Cathie Wood Unloads AI Leader After 100% Gain (Live Coverage) (Investor's Business Daily)
01:41PM	Moderna Stock Heads to Lowest Level Since 2020. Its an Evolution of Strategy, CEO Says. (Barrons.com)
01:41PM	Moderna Stock Heads to Its Lowest Level Since 2020. Its an Evolution of Strategy, CEO Says. (Barrons.com)
01:37PM	Nvidia, August PPI and jobless claims ahead of Fed cut: Morning Brief (Yahoo Finance Video)
01:00PM	Top Stock Movers Now: Kroger, Moderna, Newmont, and More (Investopedia)
12:16PM	Indexes Mixed As Inflation Eases Ahead Of Fed Meeting; Nvidia Heads Past Important Level On Analyst Views (Live Coverage) (Investor's Business Daily)
12:13PM	Moderna cuts five programmes to save $1.1bn in R&D costs (Pharmaceutical Technology)
11:11AM	Moderna CEO explains why the company is going to cut $1.1 billion in costs by 2027 (CNBC TV)
10:05AM	Moderna Outlines Post-Covid Roadmap, Cuts Research Budget, Forecasts 2025 Sales Below Expectations (Benzinga)
09:52AM	Moderna Stock Slides After Vaccine Maker Cuts R&D Plans, Drugs Pipeline (The Wall Street Journal)
09:52AM	Loading…
09:52AM	Moderna Shares Slide as Vaccine Maker Cuts R&D Spending Plans (The Wall Street Journal)
09:50AM	Moderna stock plunges after slashing R&D budget (Yahoo Finance Video)
09:41AM	Moderna Plunges as Sales View Disappoints, Research Budget Cut (Bloomberg)
09:05AM	Moderna lays out plan to slice research and development spending (Associated Press Finance)
08:43AM	Moderna Stock Drops on Plans To Cut $1.1B in R&D Costs (Investopedia)
08:38AM	Moderna Pulls Back on R&D and Delays Timeline for Profitability. The Stock Tumbles. (Barrons.com)
08:33AM	Moderna CEO: Plan to file Covid and flu combo shot with FDA by end of the year (CNBC TV)
06:14AM	Moderna expects up to $3.5B in 2025 sales (Reuters)
06:14AM	Moderna expects up to $3.5 billion in 2025 sales (Reuters)
06:00AM	Moderna To Slash $1.1 Billion From R&D Spending In Major Commercial Push (Investor's Business Daily)
06:00AM	Moderna R&D Day Highlights Progress and Strategic Priorities (ACCESSWIRE)
04:15AM	3 No-Brainer Biotech Stocks to Buy With $200 Right Now (Motley Fool)
Sep-10-24 07:30AM	Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases (PR Newswire)
04:32AM	Modernas Laval facility gains Health Canadas drug establishment licence (Pharmaceutical Technology)
Sep-09-24 01:00PM	Why Is Moderna Stock Trading Higher On Monday? (Benzinga) +5.10%
07:00AM	Moderna's Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada (ACCESSWIRE)
Sep-07-24 04:31AM	Is It Time to Buy August's Worst-Performing Nasdaq Stocks? (Motley Fool)
Sep-06-24 02:02PM	Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows (Benzinga)
07:04AM	Moderna's updated Covid-19 vaccine receives positive EMA CHMP opinion (Pharmaceutical Business Review)
07:00AM	Pandemic Darling Moderna Needs a Reality Check (The Wall Street Journal)
Sep-05-24 01:04PM	Moderna, Inc. Sued for Securities Law Violations Investors Should Contact Levi & Korsinsky for More Information MRNA (GlobeNewswire)
11:53AM	Moderna mpox mRNA vaccine shows early promise in monkey study (Pharmaceutical Technology)
08:00AM	EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1 (ACCESSWIRE)
Sep-04-24 08:35PM	Lightning Round: Moderna has to clean it up or the stock isn't going to rally, says Jim Cramer (CNBC TV)
01:14PM	Moderna Stock's Three-Year Decline Is It Time To Sell, Hold Or Buy? (Investor's Business Daily)
08:30AM	Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031 (GlobeNewswire)
07:44AM	UK MHRA grants authorisation for Moderna's updated Covid-19 vaccine (Pharmaceutical Business Review)
07:21AM	Is It Time to Buy August's Worst-Performing S&P 500 Stocks? (Motley Fool)
Sep-03-24 11:32PM	Is Merck & Co., Inc. (MRK) the Best Cancer Stock to Buy Now? (Insider Monkey) -5.76%
08:30AM	Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1 (ACCESSWIRE)
Sep-02-24 10:53AM	Novavax wins FDA emergency approval for updated Covid-19 vaccine (Pharmaceutical Technology)
07:00AM	Taiwan Food & Drug Administration Approves Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1 (ACCESSWIRE)
Sep-01-24 04:12AM	Street Calls of the Week: Moderna upgraded, downgrade for Hershey (Investing.com)
Aug-30-24 04:06PM	US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option (Associated Press Finance) -5.76%
Aug-29-24 12:00PM	New COVID vaccines are here. What to know about the latest shots as summer surge continues (Fortune)
08:00AM	Moderna Launches National Awareness Campaign to Help Drive COVID-19 Vaccination (ACCESSWIRE)
Aug-28-24 06:59PM	Moderna, Inc. (MRNA): Among The Best Medical AI Companies (Insider Monkey)
06:30AM	Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer (PR Newswire)
Aug-27-24 05:45AM	Levi & Korsinsky Reminds Moderna, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNA (PR Newswire)
Aug-26-24 07:16AM	Moderna's RSV vaccine mRESVIA gains EC approval (Pharmaceutical Business Review)
Aug-23-24 02:01PM	The FDA Approved New Covid Vaccines. Should You Get One? (The Wall Street Journal)
07:00AM	Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R) (ACCESSWIRE)
04:12AM	FDA approves updated mRNA vaccines for Covid-19 (Pharmaceutical Technology)
01:25AM	Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1 (ACCESSWIRE)
Aug-22-24 05:19PM	S&P 500 Gains and Losses Today: Moderna Falls Despite Approval of New COVID Shot (Investopedia) -6.47%
04:46PM	FDA approves updated COVID-19 vaccines from Pfizer, Moderna (Yahoo Finance Video)
02:33PM	FDA Approves Updated COVID Vaccines From Pfizer And Moderna, But Leaves Out Novavax's Shot (Benzinga)
01:47PM	Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2 (ACCESSWIRE)
01:44PM	The FDA Approved a New Covid Vaccine. Should You Get It? (The Wall Street Journal)
01:41PM	FDA Approves Updated Covid-19 Shots. Wall Street Isnt Upbeat About Sales for Pfizer and Moderna. (Barrons.com)
07:00AM	Moderna to Host Investor Event - R&D Day and Business Updates (ACCESSWIRE)
Aug-21-24 12:42AM	Covid-19: vaccine pricing varies wildly by country and company (Pharmaceutical Technology)
12:12AM	Myocarditis risks from Covid-19 vaccines are still less than the risks from Covid-19 (Pharmaceutical Technology)
Aug-20-24 11:34AM	Top 20 biopharmas market cap up 4.3% in Q2 2024 as GLP-1 drug innovators hold top spots (Pharmaceutical Technology)
Aug-19-24 05:32AM	Pipeline Moves: Modernas pandemic influenza vaccine trial completes (Clinical Trials Arena)
04:07AM	Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell? (Motley Fool)
Aug-16-24 04:21PM	Pfizer, BioNTech hit roadblock in COVID-flu vaccine trial (Yahoo Finance Video)
10:21AM	Pfizers Stumble on Flu and Covid Shot Is a Plus for Moderna (Barrons.com)
12:22AM	Pfizer and Moderna Covid-19 vaccines usage and updated safety labels (Pharmaceutical Technology)
Aug-14-24 07:00AM	Moderna and Coursera Launch Free Course on mRNA Technology (ACCESSWIRE)
Aug-13-24 02:43PM	Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows (Benzinga)
Aug-12-24 08:05AM	Pfizer builds case for RSV shot with data from immunocompromised adults (BioPharma Dive)
03:52AM	Hunting the holy grail: the marred history of HIV vaccine trials (Clinical Trials Arena)
Aug-10-24 08:18AM	CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-06-24 02:42PM	When Product Launches Struggle, Biotech Investors Reward Cost Cuts (The Wall Street Journal)
06:30AM	Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner (PR Newswire)
Aug-05-24 04:35PM	Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again. (Investor's Business Daily)
11:37AM	Midday movers: Apple, Nvidia, Intel, Coinbase and Moderna fall (Investing.com)
09:40AM	PayPal, Kellanova upgraded: Wall Street's top analyst calls (The Fly)
06:55AM	Moderna plunges on downgrade amid vaccine headwinds (Investing.com)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM
AFEYAN NOUBAR	Director	Jun 26 '24	Sale	127.22	15,000	1,908,293	2,284,015	Jun 28 07:00 PM
AFEYAN NOUBAR	Director	Jun 18 '24	Sale	133.57	15,000	2,003,561	2,299,015	Jun 21 07:00 PM
Hoge Stephen	President	Jun 17 '24	Sale	138.16	15,000	2,072,400	1,457,089	Jun 18 04:05 PM
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM
AFEYAN NOUBAR	Director	Apr 17 '24	Sale	103.38	15,000	1,550,703	2,056,931	Apr 19 07:00 PM
Hoge Stephen	President	Apr 15 '24	Sale	105.02	15,000	1,575,300	1,486,241	Apr 16 04:23 PM
AFEYAN NOUBAR	Director	Apr 10 '24	Sale	107.12	15,000	1,606,865	2,071,931	Apr 12 07:00 PM
Mock James M	Chief Financial Officer	Apr 08 '24	Sale	101.93	705	71,859	5,048	Apr 09 04:09 PM
AFEYAN NOUBAR	Director	Apr 03 '24	Sale	101.68	15,000	1,525,268	2,086,931	Apr 05 07:00 PM
AFEYAN NOUBAR	Director	Mar 27 '24	Sale	109.06	15,000	1,635,864	2,101,931	Mar 29 07:00 PM
AFEYAN NOUBAR	Director	Mar 20 '24	Sale	102.39	15,000	1,535,820	2,116,931	Mar 22 07:00 PM
Hoge Stephen	President	Mar 15 '24	Sale	103.17	15,000	1,547,550	1,501,241	Mar 19 04:39 PM
AFEYAN NOUBAR	Director	Mar 13 '24	Sale	108.54	15,000	1,628,031	2,131,931	Mar 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 08 '24	Sale	99.05	544	53,884	9,267	Mar 11 09:05 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 04 '24	Sale	94.34	117	11,038	8,673	Mar 05 05:56 PM
Hoge Stephen	President	Mar 04 '24	Sale	94.34	309	29,151	1,516,241	Mar 05 05:52 PM
Mock James M	Chief Financial Officer	Feb 29 '24	Sale	94.57	647	61,188	4,300	Mar 01 05:33 PM
Klinger Shannon Thyme	Chief Legal Officer	Feb 29 '24	Sale	94.57	670	63,363	8,557	Mar 01 05:29 PM
Hoge Stephen	President	Feb 29 '24	Sale	94.57	2,388	225,838	1,515,898	Mar 01 05:25 PM
Hoge Stephen	President	Feb 22 '24	Sale	100.00	15,000	1,500,000	1,513,433	Feb 23 04:04 PM
Hoge Stephen	President	Feb 16 '24	Sale	88.88	10,542	936,981	1,528,433	Feb 16 04:19 PM
Bancel Stephane	Chief Executive Officer	Feb 16 '24	Sale	88.88	26,351	2,342,098	5,460,224	Feb 16 04:10 PM
Hoge Stephen	President	Feb 12 '24	Sale	86.23	304	26,214	1,516,281	Feb 13 04:13 PM
Hoge Stephen	President	Jan 16 '24	Sale	103.90	15,000	1,558,500	1,516,063	Jan 17 04:12 PM
Mock James M	Chief Financial Officer	Jan 08 '24	Sale	109.75	772	84,731	3,632	Jan 09 04:08 PM
Hoge Stephen	President	Dec 27 '23	Sale	100.01	45,000	4,500,450	1,531,063	Dec 28 08:00 AM
Klinger Shannon Thyme	Chief Legal Officer	Dec 08 '23	Sale	79.09	563	44,525	7,912	Dec 11 04:03 PM
Garay Arpa	Chief Commercial Officer	Dec 06 '23	Sale	78.34	564	44,182	3,690	Dec 07 04:21 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 04 '23	Sale	79.31	111	8,804	7,336	Dec 05 04:10 PM
Hoge Stephen	President	Dec 04 '23	Sale	79.31	309	24,508	1,576,063	Dec 05 04:07 PM
Hoge Stephen	President	Nov 29 '23	Sale	79.81	1,136	90,666	1,575,721	Nov 30 04:11 PM
Hoge Stephen	President	Nov 10 '23	Sale	68.76	263	18,084	1,574,446	Nov 13 04:02 PM
AFEYAN NOUBAR	Director	Nov 01 '23	Sale	76.00	10,000	760,032	2,146,931	Nov 03 07:00 PM
AFEYAN NOUBAR	Director	Oct 25 '23	Sale	76.99	10,000	769,854	2,156,931	Oct 27 07:00 PM
AFEYAN NOUBAR	Director	Oct 11 '23	Sale	103.30	15,000	1,549,441	2,166,931	Oct 13 07:00 PM
Mock James M	Chief Financial Officer	Oct 06 '23	Sale	102.50	2,858	292,953	2,952	Oct 10 04:51 PM
AFEYAN NOUBAR	Director	Oct 04 '23	Sale	102.72	15,000	1,540,845	2,181,931	Oct 06 07:02 PM
AFEYAN NOUBAR	Director	Sep 27 '23	Sale	98.96	10,000	989,646	2,196,931	Sep 29 07:00 PM
AFEYAN NOUBAR	Director	Sep 20 '23	Sale	104.74	15,000	1,571,090	2,206,931	Sep 22 07:00 PM
Hoge Stephen	President	Sep 15 '23	Sale	112.99	15,000	1,694,850	1,574,187	Sep 18 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNA

Moderna Inc

Upgrade your FINVIZ experience